Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhen you start Mounjaro treatment, appetite shifts — sometimes dramatically. Tirzepatide, the active medicine in Mounjaro, works on two gut-hormone receptors that regulate hunger and fullness, so many people find they feel satisfied on far smaller portions than before. That biological change is real, but what you eat still matters enormously for how well the treatment works and how you feel day to day. Mounjaro is a prescription-only medicine, and a GPhC-registered prescriber will assess whether it is clinically appropriate for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is one of the most common points of confusion our prescribers hear about. The hunger signals that used to organise your day have quietened down, but you still need to eat. The challenge shifts from resisting appetite to making sure you eat enough of the right things despite not feeling particularly hungry.
Protein is the place to start. During any sustained calorie deficit, the body will draw on muscle tissue as well as fat. Adequate protein (roughly 1.2 to 1.6 grams per kilogram of body weight is a commonly cited clinical range) helps preserve lean mass. Practical options include eggs, fish, chicken, Greek yoghurt, cottage cheese, lentils and pulses. You do not need large servings; a palm-sized portion at each meal is a useful rough guide you can check in about ten seconds. For a fuller breakdown of what tends to work well at each point in treatment, the guide to what to eat on Mounjaro goes into considerably more detail.
Fibre matters too, though it needs some care. Vegetables, legumes and wholegrains support gut health and help with the constipation that some people notice on GLP-1 medicines. Adding too much fibre too quickly, however, can increase bloating, build it up gradually, drink plenty of water alongside it, and notice how your body responds.
Highly processed foods, large portions of refined carbohydrates, and very fatty or fried meals are worth reducing regardless of treatment, but they become more pressing on Mounjaro. Gastric emptying slows (food sits in the stomach longer) and a heavy, greasy meal can push nausea from mild to miserable, particularly in the first week after a dose increase.
The GI side-effect profile of tirzepatide (nausea, reflux, constipation, loose stools, burping) is well documented in clinical trial data and in the NHS tirzepatide medicines page. Most of these symptoms are most noticeable around the time of the injection and after dose increases, and they typically settle over days to a couple of weeks. But certain eating habits reliably make them worse, and they are easy to avoid once you know what to look for.
Eating too fast is a frequent culprit. Gastric emptying is already slowed; eating quickly adds volume and air before your brain has registered fullness. Pausing between bites (even just putting your fork down) makes a tangible difference for most people.
Very large single meals are similarly problematic. Smaller, more frequent eating works better for most people during Mounjaro treatment. Three modest meals with a small snack if genuinely hungry is a reasonable pattern for many, though some people do well on two. This is personal and worth discussing with your prescriber or a dietitian if you are unsure.
Carbonated drinks amplify bloating and reflux when gastric emptying is slow. Fizzy water, sodas and sparkling mixers are worth swapping for still alternatives, at least in the first months. Caffeine on an empty stomach can also aggravate nausea, if you take the Wegovy tablet version of a GLP-1, there is an explicit instruction about waiting before drinking coffee, but even for Mounjaro injections, eating before a strong coffee is sensible.
Alcohol is worth a direct mention. It interacts with Mounjaro's GI side effects, can worsen dehydration from any vomiting or diarrhoea, and provides calories with no nutritional benefit. Many people on Mounjaro find their tolerance for alcohol drops. A decision to reduce intake is worth making early in your Mounjaro treatment for weight loss.
Reduced appetite is often welcomed, until it means going through a full day on very little food and feeling exhausted. Tirzepatide suppresses appetite significantly, and some people undereat to a degree that affects energy and mood. This is not a virtuous outcome; it can slow metabolism, erode muscle, and make the treatment harder to sustain.
A workable strategy is to eat by the clock in the early weeks rather than waiting for hunger cues that may not arrive. A small, protein-led breakfast within an hour of waking, a similarly structured lunch and dinner, with attention to hydration throughout. You are aiming for enough, not for restriction on top of restriction.
Hydration deserves its own mention. Nausea reduces the desire to drink, and dehydration makes nausea worse, a self-reinforcing spiral. Small, regular sips of water through the day are more effective than trying to drink a large glass in one go. If nausea is significant and you cannot keep fluids down, that warrants contacting your prescriber or, if severe, seeking medical help promptly.
Cost is also a practical part of the picture for many people. Understanding what you are paying for in a well-supervised treatment plan is covered on the Mounjaro cost context page, which addresses what private pricing typically includes and why clinical oversight matters in that calculation.
Helpful meal structures and specific recipe ideas are collected in the Mounjaro-friendly meals guide, if you want practical inspiration rather than general principles.
Dietary changes are not just background noise during Mounjaro treatment, they are clinically relevant information. If you are eating very little and feeling faint, losing weight much faster than expected, or finding certain foods consistently trigger symptoms, your prescriber needs to know. Titration decisions (when to increase the dose, when to hold at a current level) depend partly on how you are tolerating treatment, and your diet is part of that picture.
The broader Mounjaro treatment overview covers the clinical context for these conversations. If you are seeing unexpected effects on your skin during treatment, the skin sensitivity guide addresses that specifically. And if you have questions before you start, our FAQs cover the most common ones, or you can reach the team directly through our contact page.
NICE's clinical evidence base for tirzepatide is set out in NICE technology appraisal TA1026, which forms the basis of the UK licensed use. Weight loss on Mounjaro works best as part of a deliberate plan, medicine, food and activity together, with clinical support behind it. If you would like to discuss whether this treatment is right for you, speak to our prescribers through a free consultation, reviewed the same day by a real clinician.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.